These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22445742)

  • 1. In vivo evaluation of [18F]FEAnGA-Me: a PET tracer for imaging β-glucuronidase (β-GUS) activity in a tumor/inflammation rodent model.
    Antunes IF; Haisma HJ; Elsinga PH; Sijbesma JW; Waarde Av; Willemsen AT; Dierckx RA; de Vries EF
    Nucl Med Biol; 2012 Aug; 39(6):854-63. PubMed ID: 22445742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of 1-O-(4-(2-fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-β-D-glucopyronuronate: a positron emission tomographic tracer for imaging β-glucuronidase activity in a tumor/inflammation rodent model.
    Antunes IF; Haisma HJ; Elsinga PH; van Waarde A; Willemsen AT; Dierckx RA; de Vries EF
    Mol Imaging; 2012 Feb; 11(1):77-87, E1. PubMed ID: 22418030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of [18F]-FEAnGA as a PET Tracer for beta-glucuronidase activity.
    Antunes IF; Haisma HJ; Elsinga PH; Dierckx RA; de Vries EF
    Bioconjug Chem; 2010 May; 21(5):911-20. PubMed ID: 20415436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of β-glucuronidase release by cytostatic agents in small tumors.
    Antunes IF; Haisma HJ; Elsinga PH; Di Gialleonardo V; van Waarde A; Willemsen AT; Dierckx RA; de Vries EF
    Mol Pharm; 2012 Nov; 9(11):3277-85. PubMed ID: 23009590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FEAnGA for PET of β-glucuronidase activity in neuroinflammation.
    Antunes IF; Doorduin J; Haisma HJ; Elsinga PH; van Waarde A; Willemsen AT; Dierckx RA; de Vries EF
    J Nucl Med; 2012 Mar; 53(3):451-8. PubMed ID: 22323774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation.
    van Waarde A; Jager PL; Ishiwata K; Dierckx RA; Elsinga PH
    J Nucl Med; 2006 Jan; 47(1):150-4. PubMed ID: 16391199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary biological evaluation of S-11C-methyl-D-cysteine as a new amino acid PET tracer for cancer imaging.
    Huang T; Tang G; Wang H; Nie D; Tang X; Liang X; Hu K; Yi C; Yao B; Tang C
    Amino Acids; 2015 Apr; 47(4):719-27. PubMed ID: 25534431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
    Aoki M; Watabe T; Nagamori S; Naka S; Ikeda H; Kongpracha P; Horitsugi G; Kanai Y; Shimosegawa E; Kanai Y; Hatazawa J
    Ann Nucl Med; 2019 Jun; 33(6):394-403. PubMed ID: 30820863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and comparative biological evaluation of L- and D-isomers of 18F-labeled fluoroalkyl phenylalanine derivatives as tumor imaging agents.
    Wang L; Lieberman BP; Plössl K; Qu W; Kung HF
    Nucl Med Biol; 2011 Apr; 38(3):301-12. PubMed ID: 21492778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo characterization of 2-deoxy-2-18F-fluoro-D-mannose as a tumor-imaging agent for PET.
    Furumoto S; Shinbo R; Iwata R; Ishikawa Y; Yanai K; Yoshioka T; Fukuda H
    J Nucl Med; 2013 Aug; 54(8):1354-61. PubMed ID: 23843565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single step 18F-labeling of dimeric cycloRGD for functional PET imaging of tumors in mice.
    Li Y; Liu Z; Lozada J; Wong MQ; Lin KS; Yapp D; Perrin DM
    Nucl Med Biol; 2013 Nov; 40(8):959-66. PubMed ID: 24090672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
    van Waarde A; Cobben DC; Suurmeijer AJ; Maas B; Vaalburg W; de Vries EF; Jager PL; Hoekstra HJ; Elsinga PH
    J Nucl Med; 2004 Apr; 45(4):695-700. PubMed ID: 15073267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human whole-body biodistribution and dosimetry of a new PET tracer, [(11)C]ketoprofen methyl ester, for imagings of neuroinflammation.
    Ohnishi A; Senda M; Yamane T; Sasaki M; Mikami T; Nishio T; Ikari Y; Nishida H; Shukuri M; Takashima T; Mawatari A; Doi H; Watanabe Y; Onoe H
    Nucl Med Biol; 2014 Aug; 41(7):594-9. PubMed ID: 24853403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosynthesis and Preliminary Biological Evaluation of
    Zhao J; Wang YL; Li XB; Gao SY; Liu SY; Song YK; Wang JY; Xiong Y; Ma H; Jiang L; Yang ZY; Tang GH; Chu JP
    Contrast Media Mol Imaging; 2018; 2018():8439162. PubMed ID: 30670934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells.
    van Waarde A; Been LB; Ishiwata K; Dierckx RA; Elsinga PH
    J Nucl Med; 2006 Sep; 47(9):1538-45. PubMed ID: 16954564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors.
    Qu W; Oya S; Lieberman BP; Ploessl K; Wang L; Wise DR; Divgi CR; Chodosh LA; Thompson CB; Kung HF
    J Nucl Med; 2012 Jan; 53(1):98-105. PubMed ID: 22173839
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.